These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3162444)

  • 1. Elevated serum HMFG antigen levels in breast and ovarian cancer patients measured with a sandwich ELISA.
    Ashorn P; Kallioniemi OP; Hietanen T; Ashorn R; Krohn K
    Int J Cancer Suppl; 1988; 2():28-33. PubMed ID: 3162444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of CEA, CA 19-9 and HMFG antigens in ovarian clear-cell and endometrioid carcinomas.
    Helle M; Helin H; Ashorn P; Putkinen EL; Krohn K; Wahlström T
    Pathol Res Pract; 1992 Feb; 188(1-2):74-7. PubMed ID: 1594502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511.
    Ohkawa K; Tsukada Y; Murae M; Kimura E; Takada K; Abe T; Terashima Y; Mitani K
    Br J Cancer; 1989 Dec; 60(6):953-60. PubMed ID: 2605105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the tumour-associated antigens recognized by the monoclonal antibodies HMFG-1 and 2 in serum from patients with breast cancer.
    Burchell J; Wang D; Taylor-Papadimitriou J
    Int J Cancer; 1984 Dec; 34(6):763-8. PubMed ID: 6210253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4.
    Pancino G; Osinaga E; Charpin C; Mistro D; Barque JP; Roseto A
    Br J Cancer; 1991 Mar; 63(3):390-8. PubMed ID: 1706194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinate elevation of serum markers in ovarian cancer but not in benign disease.
    Bast RC; Knauf S; Epenetos A; Dhokia B; Daly L; Tanner M; Soper J; Creasman W; Gall S; Knapp RC
    Cancer; 1991 Oct; 68(8):1758-63. PubMed ID: 1913520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-colorectal carcinoma monoclonal antibodies reactive with human milk fat globular membranes.
    Teh JG; Xing PX; McKenzie IF
    Immunol Cell Biol; 1990 Jun; 68 ( Pt 3)():207-16. PubMed ID: 1699885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucin-like carcinoma-associated antigen serum levels in patients with adenocarcinomas originating from ovary, breast and colon.
    Bon GG; Verheijen RH; Zuetenhorst JM; van Kamp GJ; Verstraeten AA; Kenemans P
    Gynecol Obstet Invest; 1996; 42(1):58-62. PubMed ID: 8840180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A short synthetic peptide (DTRPAP) induces anti-mucin (MUC-1) antibody, which is reactive with human ovarian and breast cancer cells.
    Avichezer D; Taylor-Papadimitriou J; Arnon R
    Cancer Biochem Biophys; 1998 Jun; 16(1-2):113-28. PubMed ID: 9923971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody HMFG-2 retains activity in vivo and binds to high molecular weight components expressed by metastatic breast cancers.
    Griffiths AB; Padmanabhan N; Shepherd P; Lazarus C; Maisey M; Fentiman I; Rubens R; Taylor-Papadimitriou J
    Mol Biol Med; 1986 Oct; 3(5):425-35. PubMed ID: 3550364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor-associated antigen detected by the monoclonal antibody HMFG2 in human epithelial ovarian cancer.
    Ward BG; Cruickshank DJ
    Int J Cancer; 1987 Jan; 39(1):30-3. PubMed ID: 3793268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
    Friedman EL; Hayes DF; Kufe DW
    Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple epitopes on a human breast-carcinoma-associated antigen.
    Price MR; Edwards S; Owainati A; Bullock JE; Ferry B; Robins RA; Baldwin RW
    Int J Cancer; 1985 Nov; 36(5):567-74. PubMed ID: 2414233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
    Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
    Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW
    J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures.
    Xu FJ; Yu YH; Daly L; DeSombre K; Anselmino L; Hass GM; Berchuck A; Soper JT; Clarke-Pearson DL; Boyer C
    J Clin Oncol; 1993 Aug; 11(8):1506-10. PubMed ID: 8336189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies reactive with the breast carcinoma-associated mucin core protein repeat sequence peptide also recognise the ovarian carcinoma-associated sebaceous gland antigen.
    Layton GT; Devine PL; Warren JA; Birrell G; Xing PX; Ward BG; McKenzie IF
    Tumour Biol; 1990; 11(5):274-86. PubMed ID: 1697426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-associated antigen CA 125 in patients with ovarian cancer.
    Heinonen PK; Tontti K; Koivula T; Pystynen P
    Br J Obstet Gynaecol; 1985 May; 92(5):528-31. PubMed ID: 3857939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of monoclonal antibodies to human milk-fat globule membrane antigens, with special reference to a precipitable secretory product of breast and ovarian carcinomas.
    Krohn K; Ashorn R; Helle M
    Tumour Biol; 1985; 6(1):13-23. PubMed ID: 3927470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of ovarian carcinoma-associated antigen defined by murine monoclonal antibody CF511 in sera from patients with ovarian carcinoma.
    Ohkawa K; Takada K; Hatano T; Takizawa N; Tsukada Y; Yamada K; Terashima Y; Matsuda M; Machida K
    Br J Cancer; 1991 Aug; 64(2):259-62. PubMed ID: 1892754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.